ICHR

Current Thesis

Semicap subsystem supplier (gas/chemical/fluid delivery) levered to 2026 WFE re-acceleration via ~90% customer concentration in LRCX + AMAT. B. Riley's 2026-04-13 PT raise to $75 (Buy maintained) is the sell-side flag that conviction is building into Q1. But this is a DORMANT posture play: the binary read-through lands on 2026-04-24 (LRCX print) and the own-print binary follows ~2026-05-07. Until one of those tapes prints hard, there is no fresh-entry setup — this is a watchlist name, not a fat-pitch. Archetype-2 picks & shovels sizing discipline applies if it converts to ACTIVE post-catalyst.

Bull Case

• B. Riley PT $75 on 2026-04-13 — Buy maintained, bank specifically cited momentum into Q1 print. Sell-side is front-running the number.
• LRCX Mar-quarter readthrough — LRCX commentary on etch strength tied to HBM/leading-edge would flow to ICHR with ~1-quarter lag given the subsystem supply relationship; a strong LRCX guide on 2026-04-24 is the sniff test.
• Gross margin recovery narrative intact — mgmt has guided GM exit rate back toward mid-teens as utilization normalizes; any reported GM print >14% on Q1 validates the operating-leverage thesis that gets this name re-rated from "low-margin subsystem" to "WFE torque play".
• Retail attention building pre-print — named in 2026-04-15 "5 Under-the-Radar Semi Momentum" piece; still pre-mainstream, not saturated. Squeeze fuel if Q1 beats given last-reported SI ~11% and thin float.
• Theme ACCELERATING — semicap-equipment slugged ACCELERATING as of 2026-04-19 theme scan; peer UCTT and primary customers LRCX/AMAT are all on positive tape, tide is with us.

Bear Case

• Customer concentration ~90% LRCX + AMAT — literally a two-customer business. Any CY2026 WFE cut from either on their April/May prints = immediate revenue-revision cliff for ICHR.
• Structurally low-margin subsystem — reported GM historically 11–14%; no pricing power vs more diversified peers (ENTG, UCTT). A GM miss on Q1 breaks the entire "operating leverage into recovery" re-rate story instantly.
• Earnings binary is ~2 weeks out — ICHR Q1 print ~2026-05-07 (est., confirm IR page first week of May). Any entry post-2026-05-02 is inside the 3-trading-day earnings blackout. Do NOT chase into the print.
• China / export-control tail risk — no geographic hedge; any semicap export-control tightening into H2 2026 lands directly on WFE demand and flows straight to ICHR's revenue line.
• Thin float + high SI cuts both ways — ~11% SI amplifies downside on a miss just as hard as it amplifies upside on a beat. Stops must be respected; no "it'll bounce" logic on a broken print.

Setup & Price Structure

• No live price context in this refresh run — defer precise levels to next refresh with live tape. DORMANT posture does not require a live level read.
• Reference anchor to size against if it converts: B. Riley PT $75 (2026-04-13) is the near-term bull target. Use this for R:R math once the catalyst clears, not before.
• Key technical levels to validate on next refresh with live data: 50d/200d MA cross status, prior 2026 high, volume profile around the 2026-04-13 B. Riley upgrade candle. The upgrade-candle low is the operative weekly-close invalidation.
• No setup-driven entry warranted pre-catalyst — DORMANT classification is correct. Fresh-entry logic requires either (a) post-LRCX confirmation on 2026-04-24 with clean breakout, or (b) post-ICHR-print beat with volume follow-through.
• Beginner-trap status: NOT peak retail (still "under the radar" framing per 2026-04-15 piece), NOT stretched above MA (no evidence of parabolic stretch), BUT earnings binary inside 3 weeks — blackout discipline kicks in ~2026-05-02.

Catalyst Calendar (next 30 days)

• 2026-04-24 (Thu): LRCX Mar-quarter earnings — PRIMARY read-through catalyst. LRCX guide is the pre-tell for ICHR's rev trajectory; ICHR will gap on this tape.
• ~2026-05-07 (est., confirm IR): ICHR Q1 2026 earnings — OWN binary. ICHR historically reports first week of May. Exact date TBC on IR page; operator should confirm by 2026-04-28.
• ~2026-05-15 (Thu, tentative): AMAT Apr-quarter earnings — read-through #2; second-largest customer. Post ICHR's own print but still directional for the Q2 guide arc.
• 2026-05-13–15: ITPC / SEMI industry events — watch for ICHR presence, bookings commentary, management public appearances.
• Rolling: any LRCX/AMAT pre-announcement or China export-control news — unscheduled but high-impact; monitor.

What Would Change Our Mind

• Bull confirm (promote DORMANT → ACTIVE, size against $75 PT): Q1 revenue beat >8% vs consensus AND Q2 guide above Street AND GM >14% reported on ~2026-05-07 print. Any 2 of 3 gets us to MEDIUM sizing; all 3 gets HIGH.
• Pre-catalyst tell (upgrade to HIGH watch): LRCX on 2026-04-24 raises CY2026 WFE outlook AND guides Jun-quarter above Street — get ready to enter ICHR on the Apr 25 tape with a 2-3% probe, stop under LRCX-tape-day low.
• Bear trigger (kill thesis, cut from watchlist): LRCX or AMAT cuts CY2026 WFE outlook on April/May calls. Doesn't matter what ICHR's own print says after — the proxy-on-WFE thesis is broken.
• Own-print bear trigger (SKIP even if rules fire): ICHR Q1 revenue miss OR Q2 guide below Street OR reported GM <12% on ~2026-05-07 — thesis is broken, move on, do not average down, do not "wait for bounce".
• Technical invalidation (regardless of fundamentals): Weekly close below the 2026-04-13 B. Riley-upgrade-day low on >1.5x avg volume. Price structure is telling us the sell-side call was front-run and faded.
• Theme invalidation: semicap-equipment flips from ACCELERATING to MATURING or SATURATED in the theme scan → cut watchlist priority, only play pullback setups, no breakout chases.

Correlation Notes

• UCTT — direct subsystem peer, near-identical LRCX/AMAT customer base, highest correlation (~0.85+). Treat ICHR + UCTT as the same trade for risk purposes; never double-stack.
• LRCX — primary customer (~50–60% of revenue). ICHR lags LRCX moves by 1–3 sessions on WFE news. LRCX 2026-04-24 print is the ICHR pre-tell.
• AMAT — second-largest customer (~25–35% of revenue). Similar read-through mechanics, longer lag.
• ENTG — adjacent materials/subsystem name, lower but positive correlation. Useful as the diversification tell: if ICHR moves while ENTG doesn't, the move is ICHR-specific (own catalyst), not theme-wide.
• Portfolio rule: avoid stacking ICHR with UCTT + LRCX simultaneously — effectively one concentrated WFE bet. Pick the cleanest setup among the three; don't spread conviction.